Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects

ClinicalTrials.gov ID: NCT01602328

Public ClinicalTrials.gov record NCT01602328. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of AC607 for the Treatment of Acute Kidney Injury in Cardiac Surgery Subjects

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Subjects entering the study will have undergone cardiac surgery. Those who experience kidney injury within 48 hours of their surgery will be enrolled into the study. Once enrolled, subjects will receive a single administration of AC607 or placebo. Kidney recovery will be evaluated over the subsequent 30 days and death or the need for dialysis will be evaluated within 90 days of dosing. After 90 days (evaluation period), subjects will enter a 3-year extension phase of the study to monitor safety and long-term outcomes (follow-up period).

Study identification

NCT ID
NCT01602328
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
AlloCure Inc.
Industry
Enrollment
156 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2012 (Type not available)
Primary completion
Jun 2014 (Actual)
Completion
Aug 2014 (Actual)
Last update posted
Aug 6, 2014

2012 – 2014

United States locations

U.S. sites
21
U.S. states
19
U.S. cities
20
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
University of California, San Diego San Diego California 92103 —
Stanford Hospital and Clinics Stanford California 94305-2299 —
MedStar Washington Hospital Center Washington D.C. District of Columbia 20010 —
Northwestern University Chicago Illinois 60611 —
Maine Medical Center Portland Maine 04102 —
Johns Hopkins University Baltimore Maryland 21287 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Henry Ford Hospital Detroit Michigan 48202 —
Mayo Clinic Rochester Minnesota 55905 —
Rutgers Robert Wood Johnson Medical School New Brunswick New Jersey 08903 —
Columbia University Medical Center New York New York 10032 —
Duke University Medical Center Durham North Carolina 27710 —
Ohio State University Columbus Ohio 43210 —
Lankenau Medical Center Wynnewood Pennsylvania 19096 —
UTHealth, The University of Texas Health Science Center at Houston Houston Texas 77030 —
Fletcher Allen Health Care - Renal Services Burlington Vermont 05401 —
University of Virginia Health System Charlottesville Virginia 22908 —
University of Washington Medical Center Seattle Washington 98195 —
CAMC Clinical Trials Center Charleston West Virginia 25304 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01602328, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 6, 2014 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01602328 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →